CLINICAL PHARMACOKINETICS-PHARMACODYNAMICS OF ANTICANCER DRUGS

被引：122

作者：

EVANS, WE

RELLING, MV

机构：

[1] UNIV TENNESSEE,CTR HLTH SCI,COLL PHARM,DEPT CLIN PHARM,CTR PEDIAT PHARMACOKINET & THERAPEUT,MEMPHIS,TN 38163

[2] UNIV TENNESSEE,CTR HLTH SCI,COLL MED,DEPT PEDIAT,MEMPHIS,TN 38163

来源：

CLINICAL PHARMACOKINETICS | 1989年 / 16卷 / 06期

关键词：

D O I：

10.2165/00003088-198916060-00001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：327 / 336

页数：10

共 54 条

[1]

AU JLS, 1982, CANCER RES, V42, P2930

[2] ANTI-NEOPLASTIC DRUGS - CLINICAL PHARMACOLOGY AND THERAPEUTIC USE [J].

BENDER, RA ;

ZWELLING, LA ;

DOROSHOW, JH ;

LOCKER, GY ;

HANDE, KR ;

MURINSON, DS ;

COHEN, M ;

MYERS, CE ;

CHABNER, BA .

DRUGS, 1978, 16 (01) :46-87

[3]

BENNETT CL, 1987, CANCER RES, V47, P1952

[4] BLOOD-LEVELS OF CHEMOTHERAPEUTIC-AGENTS AND CLINICAL OUTCOME [J].

BERTINO, JR .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (07) :996-996

[5]

BONNADONNA G, 1981, NEW ENGL J MED, V304, P10

[6]

BORSI JD, 1987, CANCER CHEMOTH PHARM, V19, P261

[7]

BORSI JD, 1987, CANCER, V60, P3020, DOI 10.1002/1097-0142(19871215)60:12<3020::AID-CNCR2820601227>3.0.CO

[8]

2-0

[9]

CAMPBELL AB, 1983, CANCER TREAT REP, V67, P169

[10] A DOSE AND TIME RESPONSE ANALYSIS OF THE TREATMENT OF HODGKINS-DISEASE WITH MOPP CHEMOTHERAPY [J].

CARDE, P ;

MACKINTOSH, FR ;

ROSENBERG, SA .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (02) :146-153

← 1 2 3 4 5 6 →